McKesson ROE 2010-2024 | MCK

Current and historical return on equity (ROE) values for McKesson (MCK) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
McKesson ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-03-31 $3.00B $-1.60B -200.63%
2023-12-31 $3.00B $-1.68B -204.08%
2023-09-30 $3.49B $-1.46B -222.06%
2023-06-30 $3.75B $-1.24B -247.20%
2023-03-31 $3.56B $-1.49B -226.03%
2022-12-31 $3.14B $-2.09B -190.31%
2022-09-30 $2.06B $-1.25B -155.09%
2022-06-30 $1.40B $-1.47B -134.94%
2022-03-31 $1.11B $-1.79B -164.37%
2021-12-31 $1.41B $-0.79B -759.14%
2021-09-30 $-4.81B $-0.09B 8217.09%
2021-06-30 $-4.50B $-0.05B -302.68%
2021-03-31 $-4.54B $0.18B -155.97%
2020-12-31 $-4.18B $-0.28B -99.77%
2020-09-30 $2.23B $6.09B 38.03%
2020-06-30 $0.92B $5.65B 15.33%
2020-03-31 $0.90B $5.31B 13.61%
2019-12-31 $-0.92B $6.39B -12.46%
2019-09-30 $-0.63B $6.69B -7.82%
2019-06-30 $0.60B $8.07B 6.75%
2019-03-31 $0.03B $8.29B 0.37%
2018-12-31 $-0.32B $9.39B -3.27%
2018-09-30 $0.12B $9.53B 1.15%
2018-06-30 $-0.38B $9.65B -3.53%
2018-03-31 $0.07B $10.06B 0.60%
2017-12-31 $4.80B $11.97B 41.64%
2017-09-30 $4.53B $11.36B 43.15%
2017-06-30 $4.84B $11.51B 48.06%
2017-03-31 $5.07B $11.27B 53.03%
2016-12-31 $1.91B $7.85B 21.27%
2016-09-30 $1.91B $9.62B 20.65%
2016-06-30 $2.22B $9.49B 24.49%
2016-03-31 $2.26B $9.01B 25.24%
2015-12-31 $1.96B $8.96B 22.48%
2015-09-30 $1.80B $8.87B 20.51%
2015-06-30 $1.65B $8.94B 17.97%
2015-03-31 $1.48B $8.09B 15.32%
2014-12-31 $1.71B $9.16B 16.82%
2014-09-30 $1.31B $10.53B 13.19%
2014-06-30 $1.24B $10.77B 13.39%
2014-03-31 $1.26B $10.32B 14.97%
2013-12-31 $1.15B $8.03B 15.11%
2013-09-30 $1.39B $7.99B 18.40%
2013-06-30 $1.38B $7.41B 18.52%
2013-03-31 $1.34B $7.07B 18.06%
2012-12-31 $1.60B $7.65B 21.77%
2012-09-30 $1.60B $7.72B 21.94%
2012-06-30 $1.50B $7.20B 20.93%
2012-03-31 $1.40B $6.83B 19.82%
2011-12-31 $1.30B $7.46B 18.17%
2011-09-30 $1.16B $7.12B 16.36%
2011-06-30 $1.19B $6.92B 16.98%
2011-03-31 $1.20B $7.22B 17.18%
2010-12-31 $1.13B $7.08B 15.94%
2010-09-30 $1.30B $6.82B 18.33%
2010-06-30 $1.27B $6.88B 18.02%
2010-03-31 $1.26B $7.53B 18.27%
2009-12-31 $1.20B $7.12B 18.19%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $72.887B $308.951B
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $66.122B 18.71
West Pharmaceutical Services (WST) United States $24.159B 43.30
Cardinal Health (CAH) United States $23.477B 13.43
Align Technology (ALGN) United States $19.244B 37.15
Cooper (COO) United States $18.860B 28.54
Labcorp (LH) United States $16.830B 14.49
Henry Schein (HSIC) United States $9.184B 16.34
DENTSPLY SIRONA (XRAY) United States $5.702B 14.76
Merit Medical Systems (MMSI) United States $4.760B 26.09
CONMED (CNMD) United States $2.281B 20.69
Patterson (PDCO) United States $2.145B 10.27
STAAR Surgical (STAA) United States $2.022B 77.66
Atrion (ATRI) United States $0.815B 43.51
Lifevantage (LFVN) United States $0.096B 12.34
Pro-Dex (PDEX) United States $0.067B 34.03
Biolase (BIOL) United States $0.006B 0.00